Classification of fluctuations in patients with Parkinson's disease

Neurology

Volumn 51, Issue 2 SUPPL., 1998, Pages

  Quinn, Niall P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

CONFERENCE PAPER; DISEASE CLASSIFICATION; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; DRUG RESPONSE; DYSKINESIA; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RECURRENT DISEASE; TREATMENT OUTCOME;

EID: 0031679149     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.51.2_suppl_2.s25     Document Type: Conference Paper

References (60)

1. Marsden CD, Parkes JD, Quinn N. Fluctuations of disability in Parkinson's disease: clinical aspects. In: Marsden CD, Fahn S, eds. Movement disorders. London: Butterworth, 1981:96-122.
2. Obeso JA, Grandas F, Vaamonde J, et al. Motor complications associated with chronic levodopa therapy in Parkinson's disease. Neurology 1989;11(Suppl 2):11-19.
3. Riley DE, Lang AE. The spectrum of levodopa-related fluctuations in Parkinson's disease. Neurology 1993;43:1459-1464.
4. Zappia M, Colao R, Montesanti R, et al. Long-duration response to levodopa influences the pharmacodynamics of short-duration response in Parkinson's disease. Ann Neurol 1997; 42:245-248.
5. Giladi N, McMahon D, Przedborski S, et al. Motor blocks in Parkinson's disease. Neurology 1992;42:333-339.
6. Matsuo A, Takashima H, Kishikawa M, et al. Pure akinesia: an atypical manifestation of progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1991;54:397-400.
7. Kempster PA, Frankel JP, Bovingdon M, Webster R, Lees AJ, Stern GM. Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease. J Neurol Neurosurg Psychiatry 1989;52:718-723.
8. Nutt JG, Gancher ST, Woodward WR. Does an inhibitory action of levodopa contribute to motor fluctuations? Neurology 1988;38:1553-1557.
9. Merello M, Lees AJ. Beginning-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease. J Neurol Neurosurg Psychiatry 1992;55:1024-1026.
10. Nutt JG, Holford NHG. The response to levodopa in Parkinson's disease: imposing pharmacological law and order. Ann Neurol 1996;39:561-573.
11. Nutt JG, Carter JH, Woodward WR. Long-duration response to levodopa. Neurology 1995;45:1613-1616.
12. Quinn NP, Marsden CD. Menstrual-related fluctuations in Parkinson's disease. Mov Disord 1986;1:85-87.
13. Thulin PC, Carter JH, Nichols MD, Kurth M, Nutt JG. Menstrual-cycle related changes in Parkinson's disease [abstract]. Neurology 1996;46(Suppl):A376.
14. Nutt JG. Levodopa-induced dyskinesia: review, observations, and speculations. Neurology 1990;40:340-345.
15. Lees AJ, Hardie RJ, Stern GM. Kinesigenic foot dystonia as a presenting feature of Parkinson's disease. J Neurol Neurosurg Psychiatry 1984;47:885.
16. Poewe WH, Lees AJ, Stern GM. Dystonia in Parkinson's disease: clinical and pharmacological features. Ann Neurol 1988; 23:73-78.
17. Melamed E. Early-morning dystonia: a late side effect of long term levodopa therapy in Parkinson's disease. Arch Neurol 1979;36:308-310.
18. Tolosa ES, Martin WE, Cohen HP, Jacobson RL. Patterns of clinical response and plasma dopa levels in Parkinson's disease. Neurology 1975;25:177-183.
19. Muenter MD, Sharpless NS, Tyce GM, Darley FL. Patterns of dystonia ("I-D-I" and "D-I-D") in response to L-dopa therapy for Parkinson's disease. Mayo Clin Proc 1977;52:163-174.
20. Lhermitte F, Agid Y, Signoret JL. Onset and end-of-dose levodopa-induced dyskinesias. Arch Neurol 1978;35:261-263.
21. Quinn NP, Critchley P, Marsden CD. Young onset Parkinson's disease. Mov Disord 1987;2:73-91.
22. Wenning GK, Quinn NP, Marsden CD. Facial dystonia in pathologically proven multiple system atrophy: a video report. Mov Disord 1996;11:107-109.
23. Quinn NP, Koller WC, Lang AE, Marsden CD. Painful Parkinson's disease. Lancet 1986;1:1366-1369.
24. Goetz CG, Tanner CM, Levy M, Wilson RS, Garron DC. Pain in Parkinson's disease. Mov Disord 1986;1:45-49.
25. Brown RD, Marsden CD, Quinn N, Wyke MA. Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease. J Neurol Neurosurg Psychiatry 1984;47:454-465.
26. Cantello R, Gilli M, Riccio A, Bergamasco B. Mood changes associated with "end-of-dose deterioration" in Parkinson's disease: a controlled study. J Neurol Neurosurg Psychiatry 1986; 49:1182-1190.
27. Keshavan MS, David AS, Narayanen HS, Satish P. "On-off" phenomena and manic-depressive mood shifts: case report. J Clin Psychiatry 1986;47:93-94.
28. Nissenbaum H, Quinn NP, Brown RG, Toone B, Gotham A-M, Marsden CD. Mood swings associated with the "on-off" phenomenon in Parkinson's disease. Psychol Med 1987;17:899-904.
29. Menza MA, Sage J, Marshall E, Cody R, Duvoisin R. Mood changes and "on-off" phenomena in Parkinson's disease. Mov Disord 1990;5:148-151.
30. Routh LC, Black JL, Ahlskog JE. Parkinson's disease complicated by anxiety. Mayo Clin Proc 1987;62:733-735.
31. Stein MB, Heuser IJ, Juncos JL, Uhde TW. Anxiety disorders in patients with Parkinson's disease. Am J Psychiatry 1990; 147:217-229.
32. Siemers ER, Shekhar A, Quaid K, Dickson H. Anxiety and motor performance in Parkinson's disease. Mov Disord 1993;8: 501-506.
33. Maricle RA, Nutt JG, Carter JH. Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: preliminary findings. Mov Disord 1995;10:329-332.
34. Maricle RA, Nutt JG, Valentine RJ, Carter JH. Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study. Neurology 1995;45:1757-1760.
35. Vazquez A, Jimenez-Jimenez FJ, Garcia-Ruiz P, Garcia-Urra D. "Panic attacks" in Parkinson's disease. A long-term complication of levodopa therapy. Acta Neurol Scand 1993;87:14-18.
36. Steiger MJ, Quinn NP, Toone B, Marsden CD. Off-period screaming accompanying motor fluctuations in Parkinson's disease. Mov Disord 1991;6:89-90.
37. Quinn NP, Toone B, Lang AE, Marsden CD, Parkes JD. Dopa dose-dependent sexual deviation. Br J Psychiatry 1983;142: 296-298.
38. Delis D, Direnfeld L, Alexander MP, Kaplan E. Cognitive fluctuations associated with on-off phenomenon in Parkinson's disease. Neurology 1982;32:1049-1052.
39. Girotti E, Carella F, Grassi MP, Soliveri P, Marano R, Caraceni T. Motor and cognitive performances of parkinsonian patients in the "on" and "off" phases of the disease. J Neurol Neurosurg Psychiatry 1986;49:657-660.
40. Gotham AM, Brown RG, Marsden CD. "Frontal" cognitive function in patients with Parkinson's disease "on" and "off" levodopa. Brain 1988;11:299-321.
41. Huber SJ, Shulman HG, Paulson GW, Shuttleworth EC. Dose-dependent memory impairment in Parkinson's disease. Neurology 1989;39:438-440.
42. Poewe W, Berger W, Benke T, Schelosky L. High-speed memory scanning in Parkinson's disease: adverse effects of levodopa. Ann Neurol 1991;29:670-673.
43. Goetz CG, Lutge W, Tanner CM. Autonomic dysfunction in Parkinson's disease. Neurology 1986;36:73-75.
44. Sage JI, Mark MH. Drenching sweats as an "off" phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profile. Ann Neurol 1995;37:120-122
45. Baratti M, Calzetti S. Fluctuation of arterial blood pressure during end-of-dose akinesia in Parkinson's disease. J Neurol Neurosurg Psychiatry 1984;47:1241-1243.
46. Kempster PA, Lees AJ, Crichton P, Frankel JP, Shorvon P. Off-period belching due to a reversible disturbance of oesophageal motility in Parkinson's disease and its treatment with apomorphine. Mov Disord 1989;4:47-52.
47. Bushmann M, Dobmeyer SM, Leeker L, Perlmutter JS. Swallowing abnormalities and their response to treatment in Parkinson's disease. Neurology 1989;39:1309-1314.
48. Mathers SE, Kempster PA, Swash M, Lees AJ. Constipation and paradoxical puborectalis contraction in anismus and Parkinson's disease: a dystonic phenomenon? J Neurol Neurosurg Psychiatry 1988;51:1503-1507.
49. Mathers SE, Kempster PA, Law PJ, et al. Anal sphincter dysfunction in Parkinson's disease. Arch Neurol 1989;46: 1061-1064.
50. Ashraf W, Wszolek ZK, Pfeiffer RF, et al. Anorectal function in fluctuating (on-off) Parkinson's disease: evaluation by combined anorectal manometry and electromyography. Mov Disord 1995;10:650-657.
51. Fitzmaurice H, Fowler CJ, Rickards D, et al. Micturition disturbance in Parkinson's disease. Br J Urol 1985;57:652-656.
52. Ilson J, Braun N, Fahn S. Respiratory fluctuations in Parkinson's disease [Abstract]. Neurology 1983;33(Suppl 2):113.
53. Jankovic J, Nour F. Respiratory dyskinesia in Parkinson's disease. Neurology 1986;36:303-304.
54. Corbin DO, Williams AC. Stridor during dystonic phases of Parkinson's disease. J Neurol Neurosurg Psychiatry 1987;50: 821-822.
55. Vincken WG, Daraway CM, Cosio MG. Reversibility of upper airway obstruction after levodopa therapy in Parkinson's disease. Chest 1989;96:210-212.
56. Pfeiffer RF, Sucha EL. "On-off "-induced lethal hyperthermia. Mov Disord 1989;4:338-341.
57. Lang AE, Johnson K. Akathisia in idiopathic Parkinson's disease. Neurology 1987;37:477-481.
58. Fazzini E, Diaz R, Fahn S. Restless leg in Parkinson's disease - clinical evidence for underactivity of catecholamine neurotransmission. Ann Neurol 1989;26:142.
59. Marconi R, Lefebvre-Caparros D, Bonnet A-M, Vidailhet M, Dubois B, Agid Y. Levodopa-induced dyskinesias in Parkinson's disease. Phenomenology and pathophysiology. Mov Disord 1994;9:2-12.
60. Hillen ME, Sage JI. Nonmotor fluctuations in patients with Parkinson's disease. Neurology 1996;47:1180-1183.